retatrutide and heart health Exploring Benefits for Weight Loss Diabetes Management Lilly's Retatrutide: Toward the End

Compared to a 4.3% mortality rate in the GLP-1RA group, the tirzepatide group saw a 2.4% mortality rate

Trulicity is also a once- weekly GLP-1 agonist that is ready-to-use without reconstitution in the same way that once- daily GLP-1 agonists already are

Maintaining Your Results After Treatment Transitioning Off GLP-1 Medications Deciding when and how to stop GLP-1 therapy requires careful planning with your healthcare provider

Safety considerations are critical in determining treatment duration

Contact your provider before making changes

4144 Moreover, it has been shown that GLP-1RAs also promote satiety trough the activation of the nucleus accumbens by increasing glutamatergic signaling, thus suppressing feeding behavior